Devonian Health Group Stock Today

GSD Stock  CAD 0.20  0.02  9.09%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 37

 
High
 
Low
Below Average
Devonian Health is selling for under 0.2 as of the 11th of December 2024; that is 9.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.2. Devonian Health has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 22nd of December 2022 and ending today, the 11th of December 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. The company was incorporated in 2013 and is headquartered in Qubec, Canada. DEVONIAN HEALTH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.. The company has 148.22 M outstanding shares of which 6.79 K shares are currently shorted by private and institutional investors with about 1.66 days to cover all short positions. More on Devonian Health Group

Devonian Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Devonian Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Devonian Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Devonian Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Devonian Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Devonian Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Devonian Health's financial leverage. It provides some insight into what part of Devonian Health's total assets is financed by creditors.
Liquidity
Devonian Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Devonian Health Group has accumulated 3.58 M in total debt with debt to equity ratio (D/E) of 43.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Devonian Health Group has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Devonian Health until it has trouble settling it off, either with new capital or with free cash flow. So, Devonian Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Devonian Health Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Devonian to invest in growth at high rates of return. When we think about Devonian Health's use of debt, we should always consider it together with cash and equity.

Total Cash From Financing Activities

2.62 Million
Devonian Health Group (GSD) is traded on TSX Venture Exchange in Canada and employs 6 people. Devonian Health is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 29.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Devonian Health's market, we take the total number of its shares issued and multiply it by Devonian Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Devonian Health Group classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 148.22 M outstanding shares of which 6.79 K shares are currently shorted by private and institutional investors with about 1.66 days to cover all short positions. Devonian Health Group has accumulated about 413.87 K in cash with (4.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Devonian Health Probability Of Bankruptcy
Ownership Allocation
Devonian Health holds a total of 148.22 Million outstanding shares. Devonian Health Group shows 14.2 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Devonian Ownership Details

Devonian Health Group Risk Profiles

Although Devonian Health's alpha and beta are two of the key measurements used to evaluate Devonian Health's performance over the market, the standard measures of volatility play an important role as well.

Devonian Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Devonian Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Additional Tools for Devonian Stock Analysis

When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.